How Are Emerging Markets Innovating? Evidence From The Global Bio-Pharmaceutical Industry

Working Papers

Emerging markets firms in high-technology industries have long been thought of as laggards. We argue that this paradigm needs to be reassessed. Using biotechnology as an example for a radical technology we argue that emerging market, compared to developed markets, are well positioned to pursue such technologies.Read More